New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes—such as major birth defects and pregnancy loss—than the general population, but their increased risk is not due to metformin but diabetes.
The long-awaited result of the TRIGR Study published this week shows that baby formula in which the cow’s milk proteins have been split does not prevent type 1 diabetes in children with genetic risk for type 1 diabetes.
Researchers from the University of Surrey examined in detail how likely 1.6 million people with Type 2 diabetes were to take their medication. The study combined data from clinical trials and observational studies looking at adherence rates for both tablet and injectable medicines.
Almost half of participants achieved and maintained diabetes remission at one year without antidiabetic medications
Type 2 diabetes can be reversed following an intensive weight management programme, according a randomised trial in adults who have had the condition for up to 6 years, published in The Lancet.
Among the detrimental effects of obesity is the risk of developing type-2 diabetes.
In a Diabetic Medicine (http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-5491) study that compared different regions in England, areas that provided 10 key services for diabetes foot care had lower rates of major diabetes-related lower limb amputations.